Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
基本信息
- 批准号:10616522
- 负责人:
- 金额:$ 54.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAlcoholic Liver DiseasesAlcoholsCRISPR screenCell ProliferationCell physiologyCellsChronicContractsDataDiseaseEnzymesEthanolExhibitsExposure toFRAP1 geneFrequenciesGenesGenetic TranscriptionHepaticHepatocyteHomeostasisHumanImpairmentInjuryIronIron OverloadIron Uptake InhibitionLabelLiverLiver RegenerationLobularMapsMetabolicModelingMorbidity - disease rateNatural regenerationPathogenesisPatientsPopulationProductionProliferatingReactive Oxygen SpeciesRegulationShelter facilitySourceTimeTissuesgain of functionhealinghepcidinin vivoliver cell proliferationliver injuryloss of functionmortalitynon-alcoholic fatty liver diseaseoverexpressionregenerativeresponsesingle-cell RNA sequencingsuccesstissue repair
项目摘要
PROJECT SUMMARY
Alcoholic liver disease (ALD) is exacerbated by impaired liver regeneration. The cellular basis of liver
regeneration is unclear and whether hepatocytes in different zones differ in regenerative activity is unclear, in
part because fate-mapping has only been performed on a few hepatocyte subsets. The liver is organized into
zones in which hepatocytes express different metabolic enzymes. To systematically compare the regenerative
activities of these distinct subsets of hepatocytes, we developed twelve new CreER strains. Lineage tracing
during normal homeostasis showed that cells from periportal zone 1 and pericentral zone 3 contracted in number,
while cells from mid-lobular zone 2 expanded in number. Hepatocytes in different regions of the liver thus exhibit
differences in turnover and zone 2 is an important source of new hepatocytes during homeostasis. Because
zone 2 may represent a reserve population sheltered from pericentral and periportal liver injuries, we hypothesize
that these cells also preferentially repopulate livers exposed to modest chronic injuries such as alcohol. Our
preliminary scRNA-seq and in vivo CRISPR screens identified two critical zone 2 specific genes that regulate
zone 2 hepatocyte proliferation and survival: Igfbp2 and Hamp2. Both of these secreted factors are suppressed
in NAFLD and ALD in humans, which suggests functional importance in disease. Igfbp2 operates through mTOR
and Ccnd1 to promote zone 2 hepatocyte proliferation. Hamp1 and Hamp2 encode for hepcidins, which
negatively regulate iron uptake by inhibition of iron transporters and thus protects the body from iron overload.
Patients with ALD accumulate hepatic iron through suppression of hepcidins. Free iron enhances reactive
oxygen species (ROS) production in the liver, leading to alcohol-induced liver injury. We hypothesize that ALD
pathogenesis is accelerated through the suppression of Igfbp2 and Hamp1/2, and that this involves changes in
the number or function of zone 2 hepatocytes. In Aim 1, we will first use our CreER models to systematically
determine the extent to which zone 2 cells repopulate the liver in the setting of ETOH. To understand how zone
2 cell might be involved in regeneration after ETOH, we will perturb two critical zone 2 genes using loss and gain
of function approaches. In Aim 2, we will ask if Igfbp2 is necessary and sufficient to regulate the frequency or
repopulating activities of zone 2 cells in the context of ETOH. In Aim 3, we will ask if Hamp1 and Hamp2 are
necessary and sufficient to regulate the frequency or repopulating activities of zone 2 cells. Success in this
project will for the first time define the cellular basis of regeneration in response to ETOH, allow us to focus on
critical subpopulations, and determine the importance of two critical zone 2 specific genes in ALD.
项目摘要
酒精性肝病(ALD)是由受损的肝脏再生加剧。肝脏的细胞基础
再生不清楚,不同区域的肝细胞再生活性是否不同也不清楚,
部分原因是仅对少数肝细胞亚群进行了命运映射。肝脏组织成
肝细胞表达不同代谢酶的区域。为了系统地比较
这些不同的肝细胞亚群的活性,我们开发了12个新的CreER菌株。谱系追踪
在正常体内平衡期间显示来自门静脉周围区1和中央周围区3的细胞在数量上收缩,
而来自小叶中带2的细胞在数量上扩增。因此,肝脏不同区域的肝细胞表现出
周转和区2的差异是体内平衡期间新肝细胞的重要来源。因为
2区可能代表了一个保护区,不受中心周围和门静脉周围肝损伤的影响,我们假设
这些细胞也优先在受到酒精等慢性损伤的肝脏中再生。我们
初步的scRNA-seq和体内CRISPR筛选鉴定了两个关键区2特异性基因,
2区肝细胞增殖和存活:Igfbp 2和Hamp 2。这两种分泌因子都受到抑制
在人类的NAFLD和ALD中,这表明在疾病中的功能重要性。Igfbp 2通过mTOR发挥作用
和Ccnd 1促进2区肝细胞增殖。Hamp 1和Hamp 2编码hepcidin,
通过抑制铁转运蛋白来负调节铁的摄取,从而保护身体免受铁过载。
ALD患者通过抑制hepcidins积累肝脏铁。游离铁增强活性
在肝脏中产生氧物种(ROS),导致酒精诱导的肝损伤。我们假设ALD
通过抑制Igfbp 2和Hamp 1/2加速发病,这涉及到
2区肝细胞的数量或功能。在目标1中,我们将首先使用CreER模型系统地
确定在ETOH的情况下2区细胞重新填充肝脏的程度。要了解区域如何
2细胞可能参与ETOH后的再生,我们将使用丢失和获得干扰两个关键区域2基因,
功能的方法。在目标2中,我们将询问Igfbp 2是否必要且足以调节频率,
在ETOH的情况下,2区细胞的再增殖活动。在目标3中,我们将询问Hamp 1和Hamp 2是否
这是调节2区细胞的频率或重新增殖活动所必需的和足够的。胜任这
该项目将首次定义ETOH再生的细胞基础,使我们能够专注于
关键亚群,并确定两个关键区2特异性基因在ALD中的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hao Zhu其他文献
Hao Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hao Zhu', 18)}}的其他基金
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10940417 - 财政年份:2023
- 资助金额:
$ 54.84万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10675944 - 财政年份:2023
- 资助金额:
$ 54.84万 - 项目类别:
Virtual nanostructure simulation (VINAS) portal
虚拟纳米结构模拟 (VINAS) 门户
- 批准号:
10567076 - 财政年份:2023
- 资助金额:
$ 54.84万 - 项目类别:
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
- 批准号:
10297361 - 财政年份:2021
- 资助金额:
$ 54.84万 - 项目类别:
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
- 批准号:
10458730 - 财政年份:2021
- 资助金额:
$ 54.84万 - 项目类别:
Investigating imitation SWI chromatin remodeling complexes in mammalian tissue regeneration
研究哺乳动物组织再生中的仿 SWI 染色质重塑复合物
- 批准号:
10436812 - 财政年份:2020
- 资助金额:
$ 54.84万 - 项目类别:
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
通过了解肝细胞亚群的恶性潜能和生物学来改善肝细胞癌小鼠模型
- 批准号:
10610474 - 财政年份:2020
- 资助金额:
$ 54.84万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10350701 - 财政年份:2020
- 资助金额:
$ 54.84万 - 项目类别:
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
通过了解肝细胞亚群的恶性潜能和生物学来改善肝细胞癌小鼠模型
- 批准号:
10172879 - 财政年份:2020
- 资助金额:
$ 54.84万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10166848 - 财政年份:2020
- 资助金额:
$ 54.84万 - 项目类别:
相似海外基金
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
10019450 - 财政年份:2019
- 资助金额:
$ 54.84万 - 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
9896234 - 财政年份:2019
- 资助金额:
$ 54.84万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
7990196 - 财政年份:2010
- 资助金额:
$ 54.84万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8299173 - 财政年份:2010
- 资助金额:
$ 54.84万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8102173 - 财政年份:2010
- 资助金额:
$ 54.84万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8494464 - 财政年份:2010
- 资助金额:
$ 54.84万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8693870 - 财政年份:2010
- 资助金额:
$ 54.84万 - 项目类别:
Screening of food components for the prevention of alcoholic liver diseases and their application
预防酒精性肝病的食品成分筛选及其应用
- 批准号:
21500783 - 财政年份:2009
- 资助金额:
$ 54.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of transforming growth factor-a to thr development of hepatic fibrosis in alcoholic liver diseases
转化生长因子-a对酒精性肝病肝纤维化发展的贡献
- 批准号:
09670560 - 财政年份:1997
- 资助金额:
$ 54.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunological mechanism on the generation of alcoholic liver diseases
酒精性肝病发生的免疫学机制
- 批准号:
03670349 - 财政年份:1991
- 资助金额:
$ 54.84万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




